President Trump signed into law a funding package for the Food and Drug Administration that also takes steps to lower drug prices.
The president signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals.
Trump is comited to bringing new products onto market sooner as well .
VLA Price at posting:
82.0¢ Sentiment: Buy Disclosure: Held
